Yıl: 2013 Cilt: 11 Sayı: 2 Sayfa Aralığı: 87 - 93 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Retina Sinir Lifi Tabakası ve Diyabet

Öz:
Diyabetik retinopati (DR) diyabetes mellitusun en sık görülen komplikasyonudur ve 20-65 ya arası körlü ün en önemli nedenidir. Klinik olarak retinopati geli meden önce hipergliseminin fonksiyonel de i ikliklere neden oldu u gösterilmi tir. Diyabetin seyrinde önemli olan oftalmoskopik de i iklikler olu madan bu erken fonksiyonel kayıpların tespiti ve hastalı ın ilerlemesinin önlenmesidir. Diyabetes mellitus (DM)'li hastalarda, diyabetik retinopatinin önlenmesinde metabolik kontrolün önemi bilinmektedir. Bu yazı retina sinir lifi tabakası (RSLT) ve retina sinir lifi analiz tekniklerini incelemek, diyabetes mellitus ve metabolik kontrolün RSLT'ye etkisini de erlendirmek amacını taşımaktadır.
Anahtar Kelime:

Konular: Genel ve Dahili Tıp

Retinal Nerve Fiber Layer and Diabetes

Öz:
Diabetic retinopathy (DR) is the most commonly seen complication of Diabetes mellitus (DM) and the most significant cause of blindness between the ages of 20 and 65. It was clinically demonsrated that hyperglicemia may lead to functional changes prior to the development of retinopathy. The most significant in the course of DM is that the functional deficits should be determined before ophtalmological changes occur, and the development of the disease should be prevented. It is a well-known fact that metabolic control plays a key role in the prevention of DR in patients with DM. This article aims to review the retinal nerve fiber layer (RNFL) and retinal nerve fiber analysis techniques and to evaluate the effect of diabet and metabolic control on RNFL.
Anahtar Kelime:

Konular: Genel ve Dahili Tıp
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • Schubert HD. Structure and fonction of the neural retina. In: Yanoff M, Duker JS, ed. Ophthalmology 1999 ch 8-1, p. l-2.
  • Kanski JJ. The Glaucomas. In: Clinical Ophthalmology. Butternworth Heinemann. Internationale Edition. Oxford 1994, p. 233-284.
  • Weinreb RN, Shakiba S, Zangwill L. Scanning laser polarimetry to measure the nerve fiber layer of normal and glaucomatous eyes. Am Ophthalmol 1995; 119: 627-636.
  • Quigley HA, Reacher M, Katz J, Strahlman E, Gilbert D, Scott R. Quantitative grading of nerve fiber layer photographs. Ophthalmology 1993; 100:1800-1807.
  • Sommer A, Quigley HA, Robin AL, Miller NR, Katz J, Arkell S. Evaluation of nevre fiber layer assessment. Arch Ophthalmol 1984; 102: 1766- 1771.
  • Caprioli J. The contour of the juxtapapillary nerve fiber layer in glaucoma. Ophthalmol 1990; 97: 358-366.
  • Bozkurt B, İrkeç M, Akar Y, Oran M. Glokomda retina sinir lifi tabakas1 görüntüleme yöntemleri. Türk Oftalmoloji Dergisi 2003; 33: 543-553.
  • Kruse FE, Burk ROW, Volcker HE, Zinser G, Harbarth U. Reproducibility of topografic measurements of the optic nerve head with laser tomographic scanning. Ophthalmology 1989; 96: 1320-1324.
  • Weinreb RN, Dreher AW, Coleman A, Quigley H, Shaw B, Reiter K. Histopathologic validation of Fourier-ellipsometry measurements of retinal nerve fiber layer thickness. Arch Ophthalmol 1990; 108: 557-560.
  • Dreher AW, Reiter K, Weinreb RN. Spatially resolved birefringence of the retinal nerve fiber layer assessed with retinal ellipsometer. Appl Optics 1992; 31: 3730-3735.
  • Zangwill L, Berry CA, Garden VS, Weinreb RN. Reproducibility of retardation measurements with the nerve fiber layer analyser II. Glaucoma 1997; 6: 384-389.
  • Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991; 254: 1178- 1181.
  • Puliafito CA, Hee MR, Schuman JS, Fujimoto JG. Optical Coherence Tomography of Ocular Diseases. Boston, Slack 1996; 36: 289-356.
  • Optical Coherence Tomography Scanner Owner's Manual. REV. B: Humphrey Systems. Division of Carl Zeiss, Inc. 1998.
  • American Academy of Ophthalmology. Optic nerve head and retinal nerve fiber layer analysis. Ophthalmology. 1999; 106: 1414-1424.
  • Swanson EA, Izatt FA, Hee MR, et al. In vivo retinal imaging by optical coherence tomography. Optics Letters. 1993; 18: 1864-1866.
  • Porta M, Bandello F. Diabetic Diabetologia 2002; 45: 1617-1634.
  • Oshitari T, Mitamura Y. Optical coherence tomography for complete management of patients with diabetic retinopathy. Curr Diabetes Rev. 2010;6:207-214.
  • Sokol S, Moskowitz A, Skarf B. Contrast sensitivity in diabetics with and without background retinopathy. Arch Ophthalmol 1985; 103: 51-54.
  • Prager TC, Garcia CA, Mincher CA. The pattern electroretinogram in diabetes. Am Ophthalmol 1990; 109: 279-284.
  • Amano S, Kaji Y, Oshika T, Machinami R, Nagai R. Advanced glycation end products in human optic nerve head. Br Ophthalmol 2001; 85: 52- 55. retinopathy. Tıp Araştırmaları Dergisi; 2013: 11(2): 87--93
  • Zhang L, Inoue M, Dong K, Yamamoto M. Retrograde axonal transport impairment of large and medium sized retinal ganglion cells in diabetic rat. Curr Eye Res 2000; 20: 131-136.
  • Van Dijk HW, Verbraak FD, Kok PH, et al. Decreased retinal ganglion cell layer thickness in patients with type diabetes. Invest Ophthalmol Vis Sci. 2010; 51:3660-3665.
  • Oshitari T, Hanawa K, Adachi-Usami E. Changes of macular and RNFL thicknesses measured by Stratus OCT in patients with early stage diabetes. Eye (Lond). 2009; 23:884-889.
  • Hammes HP, Federoff HJ, Brownlee M. Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med 1995; 1: 527- 534.
  • Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes; early onset and effect of insulin. Clin Invest 1998; 102: 783-791.
  • Takahashi H, Goto T, Shoji T, Tanito M, Park M, Chihara E. Diabetes-associated retinal nerve fiber damage evaluated with scanning laser polarimetry. Am Ophthalmol 2006; 142: 88-94.
  • Konigsreuther KA, Jonas JB. Optic disc morphology in diabetes mellitus. Graefes Arch Clin Exp Ophthalmol 1995; 233: 200-204.
  • Tekeli O, Turacli ME, Atmaca LS, Elhan AH. Evaluation of the optic nerve head with the heidelberg retina tomograph in diabetes mellitus. Ophthalmologica. 2008;222:168-72.
  • Chihara E, Zhang S. Analysis of diabetic optic neuropathy with topographic laser scanning system. Nippon Ganka Gakkas Zasshi 1998; 102: 431-435.
  • Klein BEK, Moss SE, Magli YL, Klein R, Hoyer C, Johnson J. Optic disc cupping: four year follow-up from the WESDR. Invest Ophthalmol Vis Sci 1989; 30: 310-315.
  • Varkonyi TT, Peto T, Degi R, at all. Impairment of visual evoked potentials: an early central manifestation of diabetic neuropathy. Diabetes Care 2002; 25: 1661-1662.
  • Lopes de Faria JM, Russ H, Costa VP. Retinal nerve fibre layer loss in patients with type diabetes mellitus without retinopathy Br Ophthalmol 2002; 86: 725-728.
  • Sugimoto M, Wakitani Y, Takahashi C, Uji Y. Detection of early diabetic change with optical coherence tomography in type diabetes mellitus patients Without retinopathy. Ophthalmologica 2005; 219: 379-385.
  • Gönül Ş, Şahin A, Özkagnıcı A, Oltulu R, Öztürk BT. Tip diabetes mellituslu olgularda retina sinir lifi tabakas1n1n degerlendirilmesi. MN Otalmoloji 2008; 15: 239-242
  • Peng PH, Lin HS, Lin S. Nerve fibre layer thinning in patients with preclinical retinopathy. Can Ophthalmol. 2009; 44:417-422.
  • Gönül Ş, Öztürk BT, Şahin A, Özkağnıcı A, Okudan S. Tip diabetes mellitus ve metabolik kontrolünün retina sinir lifi tabakası kalınlığına etkisinin değerlendirilmesi. Retina Vitreus 2010;18:149-153.
  • Early Treatment Diabetic Retinopathy Study Group. ETDRS Report No 10: Grading diabetic Tıp Araştırmaları Dergisi; 2013: 11(2): 87--93 39.
  • retinopathy from stereoscopic color fundus photographs-on extension of the modified Airlie House classification. Ophthalmology 1991; 98: 786-806.
  • LonneVille YH, Özdek Ş, Önol M, Yetkin İ, Gürelik G, Hasanreisoğlu B.The effect of blood glucose regulation on retinal nerve fiber layer thickness in diabetic patients. Ophthalmologica 2003; 217: 347-350.
APA GÖNÜL Ş, KADIOĞLU E (2013). Retina Sinir Lifi Tabakası ve Diyabet. , 87 - 93.
Chicago GÖNÜL Şaban,KADIOĞLU Ekrem Retina Sinir Lifi Tabakası ve Diyabet. (2013): 87 - 93.
MLA GÖNÜL Şaban,KADIOĞLU Ekrem Retina Sinir Lifi Tabakası ve Diyabet. , 2013, ss.87 - 93.
AMA GÖNÜL Ş,KADIOĞLU E Retina Sinir Lifi Tabakası ve Diyabet. . 2013; 87 - 93.
Vancouver GÖNÜL Ş,KADIOĞLU E Retina Sinir Lifi Tabakası ve Diyabet. . 2013; 87 - 93.
IEEE GÖNÜL Ş,KADIOĞLU E "Retina Sinir Lifi Tabakası ve Diyabet." , ss.87 - 93, 2013.
ISNAD GÖNÜL, Şaban - KADIOĞLU, Ekrem. "Retina Sinir Lifi Tabakası ve Diyabet". (2013), 87-93.
APA GÖNÜL Ş, KADIOĞLU E (2013). Retina Sinir Lifi Tabakası ve Diyabet. Tıp Araştırmaları Dergisi, 11(2), 87 - 93.
Chicago GÖNÜL Şaban,KADIOĞLU Ekrem Retina Sinir Lifi Tabakası ve Diyabet. Tıp Araştırmaları Dergisi 11, no.2 (2013): 87 - 93.
MLA GÖNÜL Şaban,KADIOĞLU Ekrem Retina Sinir Lifi Tabakası ve Diyabet. Tıp Araştırmaları Dergisi, vol.11, no.2, 2013, ss.87 - 93.
AMA GÖNÜL Ş,KADIOĞLU E Retina Sinir Lifi Tabakası ve Diyabet. Tıp Araştırmaları Dergisi. 2013; 11(2): 87 - 93.
Vancouver GÖNÜL Ş,KADIOĞLU E Retina Sinir Lifi Tabakası ve Diyabet. Tıp Araştırmaları Dergisi. 2013; 11(2): 87 - 93.
IEEE GÖNÜL Ş,KADIOĞLU E "Retina Sinir Lifi Tabakası ve Diyabet." Tıp Araştırmaları Dergisi, 11, ss.87 - 93, 2013.
ISNAD GÖNÜL, Şaban - KADIOĞLU, Ekrem. "Retina Sinir Lifi Tabakası ve Diyabet". Tıp Araştırmaları Dergisi 11/2 (2013), 87-93.